20 reports

  • PRODUCTS
  • PRODUCTS

Home care end user is expected to grow at a strong CAGR of ##. ##%.

  • Diagnostics
  • In Vitro Diagnostics
  • Medical Device
  • bioMerieux S.A.
  • Sysmex Corporation

The home care market is majorly driven by diabetes patients who have type ## diabetes.

  • Biotech Diagnostics
  • Diagnostics
  • Immunodiagnostics
  • In Vitro Diagnostics
  • Sysmex Corporation

The POC testing is becoming more common in operating rooms, emergency rooms and at home care facilities.

  • Diagnostics
  • Hematology Instrument
  • In Vitro Diagnostics
  • Insulin Delivery
  • Sysmex Corporation

Home healthcare also commands a prominent chunk of the IVD product market particularly for diabetes monitoring.

  • Diagnostics
  • In Vitro Diagnostics
  • Abbott Laboratories, Inc.
  • bioMerieux S.A.
  • Sysmex Corporation

Recently, the growing trend of increasing home healthcare services has contributed to the development of home healthcare devices for self-monitoring and remote patient monitoring.

  • In Vitro Diagnostics
  • Point Of Care Testing
  • World
  • Forecast
  • Sysmex Corporation

ABBOTT INTRODUCES BREAKTHROUGH POINT-OF-CARE TEST, THE M-PIMA™ HIV-##/ ## VIRAL LOAD (VL), AT AIDS 2018 AMSTERDAM In July 2018, Abbott introduced the m-PIMA HIV-##/ ## VL, the first viral load point-of-care test designed to provide healthcare professionals, es

  • Diagnostics
  • In Vitro Diagnostics
  • Laboratory
  • bioMerieux S.A.
  • Sysmex Corporation

THESE PRODUCTS FIND APPLICATIONS IN HEALTH MANAGEMENT, HOME MEDICAL CARE, NURSING, AND BASIC MEDICAL RESEARCH.

  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • BRIC
  • Market Segment
  • Sysmex Corporation

THERE ARE SEVERAL HUNDRED ADDITIONAL OUTPATIENT SERVICE CENTERS, HOME CARE FACILITIES AND OTHER MEDICAL FACILITIES OPERATING IN THE COUNTRY.

  • In Vitro Diagnostics
  • Mexico
  • Demand
  • Market Size
  • Sysmex Corporation

Chapter ##: The Health System in Brazil Medical Facilities There are nearly ##, ## hospitals operating throughout Brazil with additional outpatient service centers, home care facilities and other medical facilities adding to the number of facilities operating in the country.

  • In Vitro Diagnostics
  • Market Size
  • Alere Inc.
  • Becton Property Group
  • Sysmex Corporation

SPD is currently one of the leading suppliers of home pregnancy and fertility/ ovulation tests worldwide.

  • In Vitro Diagnostics
  • Infectious Disease
  • Point Of Care Testing
  • Beckman Coulter, Inc.
  • Sysmex Corporation

Further, the multiplexed POC hematology testing enhances clinical care delivery and proves useful in disaster and emergency settings, urgent and primary care settings, and home care settings.

  • In Vitro Diagnostics
  • World
  • Forecast
  • Market Size
  • Sysmex Corporation

IVD Market Analysis OFFICE; CLINIC, INCLUDING CONVENIENCE CLINIC; WORKPLACE; HOME; DISASTER CARE; AND WITHIN HOSPITAL TRIAGE AND CRITICAL CARE.

  • Diagnostics
  • In Vitro Diagnostics
  • Infectious Disease
  • Point Of Care Testing
  • Sysmex Corporation

IVD in India

3683 4200 3276

As the cost of POC devices becomes more affordable and healthcare organizations have constructed data management infrastructures, point-of-care testing has also become an attractive and economical alternative to traditional laboratory-based testing in a variety of situations, including phys

  • Healthcare
  • In Vitro Diagnostics
  • Infectious Disease
  • Laboratory
  • Sysmex Corporation

Hospitals are only one source of care for Vietnamese.

  • In Vitro Diagnostics
  • Abbott Laboratories, S.A.
  • bioMerieux S.A.
  • Roche Group
  • Sysmex Corporation
  • Executive Summary

The tests are available for both point of care (POC and at-home diagnostics.

  • Diagnostics
  • In Vitro Diagnostics
  • Laboratory
  • Point Of Care Testing
  • Sysmex Corporation

IVD in China

3070 3500 2730

By 2040, developing countries including China are likely to be home to more than ## billion people aged ## and over, ##% of the projected world total.

  • Healthcare
  • In Vitro Diagnostics
  • Infectious Disease
  • Market Size
  • Sysmex Corporation

The traditional rational for a POC test is one where an immediate answer will impact patient care.

  • Diagnostics
  • In Vitro Diagnostics
  • Laboratory
  • Beckman Coulter, Inc.
  • Sysmex Corporation
  • BRAZILIAN IVD MARKET BY SEGMENT

FDA approved rapid point-of-care test that detects both HIV-##/ ## antibodies and the HIV-## p## antigen, which can appear days after infection and prior to HIV-##/ ## antibodies.

  • In Vitro Diagnostics
  • Point Of Care Testing
  • Alere Inc.
  • Beckman Coulter, Inc.
  • Sysmex Corporation

THESE PRODUCTS FIND APPLICATIONS IN HEALTH MANAGEMENT, HOME MEDICAL CARE, NURSING, AND BASIC MEDICAL RESEARCH.

  • In Vitro Diagnostics
  • East Asia
  • Forecast
  • Market Segment
  • Sysmex Corporation

REAL-WORLD EVIDENCE SHOULD BE GENERATED IN THE COURSE OF CLINICAL OR HOME CARE, AND WILL COMPLY WITH ROBUST METHODOLOGICAL STANDARDS.

  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • North America
  • Forecast
  • Sysmex Corporation